On June 1, 2021, we began transitioning genetic testing to the new Prior Authorization and Notification platform. Since the transition began, we have offered a prior authorization penalty waiver for genetic and molecular tests.
Beginning Jan. 1, 2022, the penalty waiver will no longer be in effect. This means that, for those genetic and molecular tests that require prior authorization/advanced notification, ordering providers must request prior authorization using the Prior Authorization and Notification platform or by calling 877-303-7736.
Performing laboratories are able to submit advance notifications. If a test requires prior authorization with clinical criteria, the request must be submitted by the ordering provider.